Becton, Dickinson and Company (BDX) Stock Forecast & Price Target

Becton, Dickinson and Company
Bull Case

Here are some ways that investors could benefit from investing in Becton, Dickinson and Company:

• The current stock price is around $147.91, which is significantly lower than its 12-month high of $187.35, potentially offering a buying opportunity for investors looking for value.
• Becton, Dickinson and Company reported a quarterly revenue increase of 5.2% compared to the same quarter last year, indicating strong growth and demand for its medical products.
• The company has a solid return on equity of 15.37%, suggesting effective management and profitability, which can be attractive to investors seeking reliable returns.
• With a dividend yield of approximately 2.7%, Becton, Dickinson and Company provides a steady income stream for investors, which can be particularly appealing in uncertain market conditions.
• The firm has set its FY 2026 earnings per share guidance at 12.520-12.720, indicating positive expectations for future profitability and growth.